Citigroup’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$604 Buy
+265
New +$770 ﹤0.01% 5524
2025
Q4
Sell
-32
Closed -$80 6356
2025
Q3
$80 Sell
32
-2,259
-99% -$6.99K ﹤0.01% 5822
2025
Q2
$7.61K Buy
2,291
+2,259
+7,059% +$8.05K ﹤0.01% 5225
2025
Q1
$134 Hold
32
﹤0.01% 5428
2024
Q4
$154 Hold
32
﹤0.01% 5676
2024
Q3
$118 Sell
32
-8,236
-100% -$29.2K ﹤0.01% 5534
2024
Q2
$33.5K Sell
8,268
-1,720
-17% -$7.34K ﹤0.01% 4799
2024
Q1
$47.8K Buy
9,988
+4,242
+74% +$24.7K ﹤0.01% 4652
2023
Q4
$43.4K Sell
5,746
-1,532
-21% -$12.6K ﹤0.01% 4600
2023
Q3
$74.6K Sell
7,278
-6,060
-45% -$74.8K ﹤0.01% 4019
2023
Q2
$184K Sell
13,338
-2,616
-16% -$39.3K ﹤0.01% 3928
2023
Q1
$259K Sell
15,954
-3,402
-18% -$64.1K ﹤0.01% 3576
2022
Q4
$343K Buy
19,356
+4,142
+27% +$82.3K ﹤0.01% 3418
2022
Q3
$297K Sell
15,214
-2,054
-12% -$43.6K ﹤0.01% 3558
2022
Q2
$344K Sell
17,268
-5,353
-24% -$120K ﹤0.01% 3507
2022
Q1
$583K Buy
22,621
+450
+2% +$11.7K ﹤0.01% 3402
2021
Q4
$560K Sell
22,171
-16,158
-42% -$447K ﹤0.01% 3709
2021
Q3
$1.03M Sell
38,329
-2,285
-6% -$65.8K ﹤0.01% 3061
2021
Q2
$1.29M Buy
40,614
+11,023
+37% +$350K ﹤0.01% 3023
2021
Q1
$1.04M Sell
29,591
-22,614
-43% -$787K ﹤0.01% 2952
2020
Q4
$1.67M Buy
52,205
+42,740
+452% +$1.32M ﹤0.01% 3035
2020
Q3
$299K Sell
9,465
-23,771
-72% -$787K ﹤0.01% 4287
2020
Q2
$1.18M Buy
33,236
+25,403
+324% +$882K ﹤0.01% 3378
2020
Q1
$225K Sell
7,833
-233,309
-97% -$6.11M ﹤0.01% 4628
2019
Q4
$5.67M Buy
241,142
+230,272
+2,118% +$5.16M ﹤0.01% 1937
2019
Q3
$196K Sell
10,870
-13,301
-55% -$220K ﹤0.01% 5160
2019
Q2
$379K Buy
24,171
+5,449
+29% +$107K ﹤0.01% 4696
2019
Q1
$427K Buy
18,722
+10,591
+130% +$239K ﹤0.01% 4349
2018
Q4
$189K Sell
8,131
-33,998
-81% -$907K ﹤0.01% 5075
2018
Q3
$1.39M Buy
42,129
+26,462
+169% +$989K ﹤0.01% 3121
2018
Q2
$690K Buy
15,667
+9,125
+139% +$353K ﹤0.01% 3746
2018
Q1
$273K Buy
6,542
+6,122
+1,458% +$283K ﹤0.01% 4620
2017
Q4
$19K Sell
420
-4,503
-91% -$177K ﹤0.01% 6757
2017
Q3
$164K Sell
4,923
-1,949
-28% -$79.3K ﹤0.01% 5149
2017
Q2
$279K Sell
6,872
-7,058
-51% -$219K ﹤0.01% 4508
2017
Q1
$280K Sell
13,930
-34,762
-71% -$735K ﹤0.01% 4369
2016
Q4
$1.12M Buy
48,692
+21,504
+79% +$461K ﹤0.01% 3557
2016
Q3
$551K Buy
27,188
+12,432
+84% +$251K ﹤0.01% 3813
2016
Q2
$277K Sell
14,756
-1,484
-9% -$27.3K ﹤0.01% 4198
2016
Q1
$291K Buy
16,240
+5,815
+56% +$99.6K ﹤0.01% 4725
2015
Q4
$178K Buy
10,425
+2,706
+35% +$45.5K ﹤0.01% 4853
2015
Q3
$124K Buy
7,719
+3,936
+104% +$66K ﹤0.01% 4832
2015
Q2
$65K Sell
3,783
-5,736
-60% -$96.2K ﹤0.01% 5328
2015
Q1
$158K Sell
9,519
-10,179
-52% -$158K ﹤0.01% 4721
2014
Q4
$282K Buy
19,698
+13,528
+219% +$182K ﹤0.01% 4410
2014
Q3
$84K Buy
6,170
+1,348
+28% +$18.8K ﹤0.01% 4911
2014
Q2
$65K Sell
4,822
-7,015
-59% -$92.6K ﹤0.01% 4977
2014
Q1
$158K Buy
11,837
+4,107
+53% +$56.9K ﹤0.01% 4572
2013
Q4
$129K Buy
7,730
+6,121
+380% +$95.6K ﹤0.01% 5034
2013
Q3
$26K Buy
1,609
+568
+55% +$8.86K ﹤0.01% 5753
2013
Q2
$13K Buy
+1,041
New +$13.6K ﹤0.01% 5998

Other funds holding PETS

Citigroup's PETS Position: Q1 2026 in Review

Citigroup opened a new position in PetMed Express (PETS) in Q1 2026: 265 shares worth $604. The stake represents ﹤0.01% of the portfolio and ranks #5524 among its holdings. This is a return to the name: Citigroup previously reported a position in PETS as recently as Q3 2025.

Citigroup first reported a position in PETS in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.67M in Q4 2019. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

  • Citigroup held 265 shares of PetMed Express worth $604 as of Q1 2026.
  • PetMed Express was a new Citigroup position in Q1 2026.
  • PetMed Express made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5524 holding.
  • Citigroup first reported a position in PetMed Express in Q2 2013 and has held it in 51 quarters since.
  • Citigroup's PetMed Express position peaked at $5.67M in Q4 2019.
  • 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.